Evidence map›Paper›PMID 40821521›Full record

ArticleACS omega2025

The Use of dSTORM-Based Single Exosome Analysis To Study Tetraspanin Abundance in Extracellular Vesicles.

Komal Abhange, Siobhan King, Nicole Peterson, Vaibhav Sahai, Kyle C Cuneo, David M Lubman

Abstract read
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Osteogenic Effects of Brown AlgaePreventive nutrition and food science · 2025
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Komal AbhangeDepartment of Surgery, The University of Michigan Medical Center, 1150 W. Medical Center Drive, Building MSRB1 Rm A510B, Ann Arbor, Michigan 48109, United States.ORCID https://orcid.org/0009-0001-6834-928X
Siobhan KingOxford Nanoimaging Limited, Oxford OX2 8TA, U.K.
Nicole PetersonDepartment of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Ann Arbor, Michigan 48198, United States.
Vaibhav SahaiDepartment of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Ann Arbor, Michigan 48198, United States.ORCID https://orcid.org/0000-0003-1892-1548
Kyle C CuneoDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan 48109, United States.
David M LubmanDepartment of Surgery, The University of Michigan Medical Center, 1150 W. Medical Center Drive, Building MSRB1 Rm A510B, Ann Arbor, Michigan 48109, United States.ORCID https://orcid.org/0000-0001-7731-0232

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Veerabhadran Baladandayuthapani · 1988 to 2026
$178.2M
Universal Internal Standard for Reproducible Accurate Quantification of Exosome Protein MarkersR01CA258240 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI David M. Lubman, Tujin Shi · 2022 to 2026
$2.3M
NCI NIH HHS P30 CA046592NCI NIH HHS R01 CA258240
6 · The paper itself

Abstract

Serum-derived exosomes are membrane-enclosed nanovesicles secreted by cells, typically between 30 and 120 nm in diameter. Exosomes can be identified by the presence of tetraspanin protein markers including CD9, CD81, and CD63 among others. The relative amounts of these exosomal markers and their location in the exosomes are also related to their source of origin. The ability to investigate these different markers and their locations in individual and multiple exosomes was obtained using an optical imaging technique known as dSTORM (direct stochastic optical reconstruction microscopy) which can overcome the diffraction limit for detection of these nanovesicles. The use of the dSTORM imaging method has allowed us to evaluate the relative abundance of tetraspanin markers CD9, CD81, and CD63 in exosomes and the size of exosomes related to these markers. We also compared the presence of these markers in normal versus pancreatic cancer serum samples and against exosomes secreted from cell lines. We found that CD9 is generally the most abundant marker in exosomes and is found near the surface of the exosomes, although CD81 and CD63 abundance is also significant. This result is consistent with our prior DIA mass spectrometry data and may be important in future work involving analysis of exosomes as markers of disease.

Identifiers

PMID40821521
PMCPMC12355246

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.